-The Business Standard The tussle between the US Food and Drug Administration (US FDA) and Ranbaxy is likely to hit the plans of Indian pharmaceutical companies of making it big in the US generic drugs market. Apart from the fact that their image may take a beating, the additional scrutiny on abbreviated new drug applications (ANDAs) from India would lead to more delays in drug approvals. Last week, Ranbaxy had agreed to...
More »SEARCH RESULT
Mandatory CSR in India: A Bad Proposal-Aneel Karnani
-Stanford Social Innovation Review Looked at from the perspective of the political right, and the left, and the center, the proposed law making CSR mandatory is a really bad idea. Companies all over the world are under increasing pressure to demonstrate that they are responsible citizens, with about 70 percent of large companies in Europe and the Americas reporting on their corporate social responsibility (CSR) initiatives. Despite this, the very concept...
More »Ranbaxy's dark chapter-Bhupesh Bhandari
-The Business Standard Why have Indian authorities woken up to the Ranbaxy case only now? The matter had been simmering for several years The Ranbaxy affair is one of the darkest chapters of India's business history. The company has admitted it fudged data so that it could launch its products in the United States. It has now paid $500 million as a penalty to settle the case. It is worse than Ramalinga...
More »Media cross-holding in cross hairs -Prashant Jha
-The Hindu As TRAI prepares to regulate ownership of news organisations to ensure pluralism, big media houses fear shrinking profits and state control by proxy Rahul Khullar, the straight-talking chairman of the Telecom Regulatory Authority of India (TRAI), listened attentively to the senior management executive of Bennett Coleman and Co. Limited, one of India's largest media conglomerates. The latter disagreed with the premise of the discussion - that there was a "problem,"...
More »From Bofors to 2G, the same fate-Arun Kumar
-The Hindu The parliamentary committees on the howitzer scam and the stock market scandal protected the powerful and failed to fix accountability. The same is true in the spectrum case The current political situation brings back memories of 1989. The Prime Minister then was under a cloud in the Bofors scam. Many of his close associates like Lalit Suri and Ajitabh Bachchan were accused of wrong-doing. Today, Prime Minister Manmohan Singh and...
More »